Standout Papers

Immune dysregulation as a driver of idiopathic pulmonary fibrosis 2021 2026 2022 2024177
  1. Immune dysregulation as a driver of idiopathic pulmonary fibrosis (2021)
    Kevin Shenderov, Samuel L. Collins et al. Journal of Clinical Investigation

Immediate Impact

3 by Nobel laureates 28 from Science/Nature 74 standout
Sub-graph 1 of 22

Citing Papers

Natural killer cell therapies
2024 StandoutNature
SLC38A2 and glutamine signalling in cDC1s dictate anti-tumour immunity
2023 StandoutNature
3 intermediate papers

Works of Samuel L. Collins being referenced

Egr-2 and Egr-3 are negative regulators of T cell activation
2005

Author Peers

Author Last Decade Papers Cites
Samuel L. Collins 336 393 106 327 34 1.0k
Dana Thomasová 187 479 92 663 23 1.4k
Siân Lax 143 291 70 445 31 1.2k
Andrea‐Hermina Györfi 309 182 94 390 30 1.1k
Hong Meng 186 418 78 346 36 1.1k
Neil Ahluwalia 626 252 114 216 27 1.2k
Brahmananda R. Chitteti 106 266 88 519 37 1.3k
Timothy Semple 165 538 59 286 28 1.2k
Nunzia Caporarello 291 129 71 482 37 1.1k
Haiyan Chu 261 297 100 346 41 1.1k
Katri Vuopala 264 525 103 520 37 1.3k

All Works

Loading papers...

Rankless by CCL
2026